Signal Pharmaceuticals, Inc.

Signal Pharmaceuticals is an integrated drug discovery company focused on identifying new classes of small molecule drugs that selectively regulate disease-associated genes. Signal is building a substantial pipeline of drug candidates through a corporate strategy that emphasizes: (i) integrating advanced target-to-drug discovery technologies, (ii) leveraging drug targets and drug candidates across multiple therapeutic areas, (iii) building a partner-funded drug discovery and development business, and (iv) becoming a specialty pharmaceutical company focused on the proliferative disease field. Applying its target-to-drug capabilities, Signal has built a large and diverse portfolio of drug leads in 6 therapeutic areas, including immune-inflammatory diseases and cancer, cardiovascular and neurological diseases, osteoporosis and viral infections.

Activity:

Product / Technology type(s) covered:

- Generics
- Pharmaceuticals / Therapeutics

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: